Stay updated on RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T21:41:48.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T13:45:18.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.1 to v3.4.2, indicating a minor front-end update. No substantive study data or content changes are evident.
    Difference
    0.0%
    Check dated 2026-02-14T15:47:57.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision from v3.4.0 to v3.4.1; no changes to study content or site functionality were observed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:09:17.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no study details, contacts, locations, or outcomes were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T04:32:37.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing Beijing Municipality and Liaoning as study sites, replacing the previous location groupings.
    Difference
    0.2%
    Check dated 2025-12-23T12:41:14.000Z thumbnail image

Stay in the know with updates to RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.